Methods of treating CKD using predictors of fluid retention

Donald E Kohan; Hiddo Heerspink; Dick de Zeeuw; Blai Coll; Dennis Andress

Methods of treating CKD using predictors of fluid retention

Donald E Kohan (Uitvinder), Hiddo Heerspink (Uitvinder), Dick de Zeeuw (Uitvinder), Blai Coll (Uitvinder), Dennis Andress (Uitvinder)

Onderzoeksoutput

Samenvatting

The disclosure relates to methods of treating chronic kidney disease and diabetic nephropathy using predictors of fluid retention to minimize the risk of adverse events. The methods disclosed are particularly useful in treatments involving endothelin receptor antagonists, and more particularly, atrasentan and pharmaceutically acceptable salts thereof.

Originele taal-2	English
Octrooinummer	WO2016073846
Prioriteitsdatum	07/11/2014
Status	Published - 12-mei-2016

Toegang tot document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2016073846A1&KC=A1&FT=D&ND=3&date=20160512&DB=&locale=en_EP

Handle.net

Permanente koppeling

Citeer dit

@misc{6ab210bf75f3477c8fbefbf4487b1510,

title = "Methods of treating CKD using predictors of fluid retention",

abstract = "The disclosure relates to methods of treating chronic kidney disease and diabetic nephropathy using predictors of fluid retention to minimize the risk of adverse events. The methods disclosed are particularly useful in treatments involving endothelin receptor antagonists, and more particularly, atrasentan and pharmaceutically acceptable salts thereof.",

author = "Kohan, {Donald E} and Hiddo Heerspink and {de Zeeuw}, Dick and Blai Coll and Dennis Andress",

year = "2016",

month = may,

day = "12",

language = "English",

type = "Patent",

note = "WO2016073846",

}

TY - PAT

T1 - Methods of treating CKD using predictors of fluid retention

AU - Kohan, Donald E

AU - Heerspink, Hiddo

AU - de Zeeuw, Dick

AU - Coll, Blai

AU - Andress, Dennis

PY - 2016/5/12

Y1 - 2016/5/12

N2 - The disclosure relates to methods of treating chronic kidney disease and diabetic nephropathy using predictors of fluid retention to minimize the risk of adverse events. The methods disclosed are particularly useful in treatments involving endothelin receptor antagonists, and more particularly, atrasentan and pharmaceutically acceptable salts thereof.

AB - The disclosure relates to methods of treating chronic kidney disease and diabetic nephropathy using predictors of fluid retention to minimize the risk of adverse events. The methods disclosed are particularly useful in treatments involving endothelin receptor antagonists, and more particularly, atrasentan and pharmaceutically acceptable salts thereof.

M3 - Patent

M1 - WO2016073846

ER -

Methods of treating CKD using predictors of fluid retention

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit